Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously

NCT00333515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Chemical Terrorism
Chemical Warfare

Interventions

DRUG: Human Butyrylcholinesterase (HuBChE) derived from human plasma
DRUG: Placebo: Normal saline

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]